SEC Filings
| Company Name | Form Type | SEC Filings |
|---|---|---|
| Invus, L.P. | 4 | |
| Invus Advisors, L.L.C. | 4 | |
| Invus Public Equities, L.P. | 4 | |
| Invus Public Equities Advisors, LLC | 4 | |
| Westend S.A. | 4 | |
| Artal International S.C.A. | 4 | |
| LEXICON PHARMACEUTICALS, INC. | 4 | Financial Statements |
| Artal Group S.A. | 4 | |
| LAYMON JOE W | 4 | |
| Twelve Seas Investment Co. II | DEF 14A | |
| Metis Equity Trust- Metis International Climate Aligned Index Portfolio | D/A | |
| O'Donnell John P | 4 | |
| Chirekos Nicholas J. | 4 | |
| Hewlett Packard Enterprise Co | 4 | Financial Statements |
| RUSSO PATRICIA F | 4 | |
| Prospect Floating Rate & Alternative Income Fund, Inc. | SC TO-I/A | |
| TOELDTE ALEXANDER | 4 | |
| Cerevel Therapeutics Holdings, Inc. | 4 | |
| COLES N ANTHONY | 4 | |
| REINER GARY M | 4 | |
| HUNT KEVIN J | 4 | |
| Canfield Stuart | 4 | |
| Galileo | 13F-HR | |
| Ginkgo Bioworks Holdings, Inc. | 4 | |
| SLOAN HARRY | 4 | |
| Forrest Eric | 4 | |
| Bonstein Sara | 144 | |
| Lemaitre Dan | 4 | |
| GLOBUS MEDICAL INC | 4 | Financial Statements |
| MCDONALDS CORP | FWP | Financial Statements |
| BIOMARIN PHARMACEUTICAL INC | 8-K | Financial Statements |
| PSquared Asset Management AG | 13F-HR | |
| BTG Pactual Asset Management S.A. DTVM | 13F-NT | |
| Ozzie Raymond E | 4 | |
| RAISBECK DAVID W | 144 | |
| EASTMAN CHEMICAL CO | 144 | Financial Statements |
| INNOVATIVE FOOD HOLDINGS INC | 10-Q | |
| PARKS AMERICA, INC | 10-Q | |
| Finwise Bancorp | 10-Q | Financial Statements |
| Destination Wealth Management | 13F-HR | |
| POPWELL DAVID T | 4 | |
| Capital Markets Advisors, LLC | MA/A | |
| UniBank Fiscal Advisory Services, Inc. | MA/A | |
| LIGHTPATH CAPITAL, INC | X-17A-5/A |